This program focuses on exploring RNA-based clinical applications in cancer therapy. The training will include specialized knowledge of RNA and tumor biology, identification and design of RNA-based biomarkers and therapeutics, as well as critical thinking and empirical research capabilities.

Participants that have completed the training may be considered for funding support to study in TMU’s Master’s Program or Ph.D. program of Cancer Biology and Drug Development at Taipei Medical University. Participants will be eligible to receive a monthly living subsidy of TWD 15,000 per month.

Program duration: March 1, 2023 – February 29, 2024

Application duration: January 1 – December 31, 2023

Applicants should submit their application at least two months before their intended starting date of the program.